Deep brain stimulation in schizophrenia;Tiefe Hirnstimulation bei der Schizophrenie

Fortschritte der Neurologie Psychiatrie

Volumn 79, Issue 11, 2011, Pages 632-641

  Kuhn, J ^a   Bodatsch, M ^a   Sturm, V ^a   Lenartz, D ^a   Klosterkotter J ^a   Uhlhaas, P J ^b   Winter, C ^c   Grundler T O J ^d  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^b MAX PLANCK INSTITUTE FOR BRAIN RESEARCH   (Germany)

^c UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^d MAX PLANCK INSTITUTE FOR NEUROLOGICAL RESEARCH   (Germany)

Author keywords

deep brain stimulation; neural oscillations; schizophrenia; translational medicine

Indexed keywords

ARTICLE; BRAIN DEPTH STIMULATION; COMPARATIVE STUDY; DISEASE MODEL; DOPAMINERGIC TRANSMISSION; FEASIBILITY STUDY; MENTAL DISEASE; NONHUMAN; OSCILLATION; SCHIZOPHRENIA; THEORY;

ANIMALS; CEREBRAL CORTEX; DEEP BRAIN STIMULATION; DISEASE MODELS, ANIMAL; DOPAMINE; ELECTROENCEPHALOGRAPHY; HABENULA; HUMANS; MAGNETIC RESONANCE IMAGING; NUCLEUS ACCUMBENS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SYNAPTIC TRANSMISSION;

EID: 80055108397     PISSN: 07204299     EISSN: 14393522     Source Type: Journal    
DOI: 10.1055/s-0031-1281733     Document Type: Article

References (117)

1. Benabid A L., Pollak P, Louveau A et al. Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson disease. Appl Neurophysiol 1987 50 (1 6) 344-346 (Pubitemid 18043161)
2. Deuschl G, Schade-Brittinger C, Krack P et al. A randomized trial of deep-brain stimulation for Parkinsons disease. N Engl J Med 2006 355 (9) 896-908 (Pubitemid 44315982)
3. Kupsch A, Benecke R, Muller J et al. Pallidal deep-brain stimulation in primary generalized or segmental dystonia. N Engl J Med 2006 355 (19) 1978-1990 (Pubitemid 44708017)
4. Schuurman P R., Bosch D A., Bossuyt P M. et al. A comparison of continuous thalamic stimulation and thalamotomy for suppression of severe tremor. N Engl J Med 2000 342 (7) 461-468 (Pubitemid 30100233)
5. Deuschl G, Schade-Brittinger C, Krack P et al. A randomized trial of deep-brain stimulation for Parkinsons disease. The New England journal of medicine 2006 355 (9) 896-908 (Pubitemid 44315982)
6. Skuban T, Flohrer, Klosterkoetter J et al. Psychiatrische Nebenwirkungen der tiefen Hirnstimulation bei M. Parkinson. submitted
7. Nuttin B, Cosyns P, Demeulemeester H et al. Electrical stimulation in anterior limbs of internal capsules in patients with obsessive-compulsive disorder. Lancet 1999 354 (9189) 1526 (Pubitemid 29502111)
8. Vandewalle V, Linden C van der, Groenewegen H J. et al. Stereotactic treatment of Gilles de la Tourette syndrome by high frequency stimulation of thalamus. Lancet 1999 353 (9154) 724 (Pubitemid 29103812)
9. Kuhn J, Gründler T OJ, Lenartz D et al. Deep brain stimulation for psychiatric disorders. Dtsch Arztebl Int 2010 107 (7) 105-113
10. Kuhn J, Gründler T OJ, Bauer R et al. Observations on cognitive control during successful deep brain stimulation of the nucleus accumbens in severe alcohol dependence. submitted
11. Kuhn J, Lenartz D, Huff W et al. Remission of alcohol dependency following deep brain stimulation of the nucleus accumbens: valuable therapeutic implications? J Neurol Neurosurg Psychiatry 2007 78 (10) 1152-1153
12. Laxton A W., Tang-Wai D F., McAndrews M P. et al. A phase I trial of deep brain stimulation of memory circuits in Alzheimers disease. Ann Neurol 2010 68 (4) 521-534
13. Huys D, Möller M, Kim E et al. Die historischen Grundlagen der tiefen Hirnstimulation bei psychiatrischen Erkrankungen. Nervenarzt 2011 Aug 25 [Epub ahead of print]
14. Trottenberg T, Volkmann J, Deuschl G et al. Treatment of severe tardive dystonia with pallidal deep brain stimulation. Neurology 2005 64 (2) 344-346
15. Damier P, Thobois S, Witjas T et al. Bilateral deep brain stimulation of the globus pallidus to treat tardive dyskinesia. Archives of general psychiatry 2007 64 (2) 170-176 (Pubitemid 46220774)
16. Cipriani A, Boso M, Barbui C. Clozapine combined with different antipsychotic drugs for treatment resistant schizophrenia. Cochrane database of systematic reviews 2009 3 CD006324
17. Kirkpatrick B, Fenton W S., Carpenter W T. et al. The NIMH-MATRICS consensus statement on negative symptoms. Schizophrenia bulletin 2006 32 (2) 214-219
18. Os J van, Kapur S Jr. Schizophrenia. Lancet 2009 374 (9690) 635-645
19. Wittchen H U., Essau C A., Zerssen D von et al. Lifetime and six-month prevalence of mental disorders in the Munich Follow-Up Study. European archives of psychiatry and clinical neuroscience 1992 241 (4) 247-258
20. Perala J, Suvisaari J, Saarni S I. et al. Lifetime prevalence of psychotic and bipolar I disorders in a general population. Archives of general psychiatry 2007 64 (1) 19-28 (Pubitemid 46041735)
21. Skantze K. Subjective quality of life and standard of living: a 10-year follow-up of out-patients with schizophrenia. Acta psychiatrica Scandinavica 1998 98 (5) 390-399 (Pubitemid 28529684)
22. Pinikahana J, Happell B, Hope J et al. Quality of life in schizophrenia: a review of the literature from 1995 to 2000. International journal of mental health nursing 2002 11 (2) 103-111
23. Castle D J., Morgan V. Epidemiology. In: Mueser K T. Jeste D V. eds Clinical handbook of schizophrenia. New York The Guilford Press 2008 14-24
24. Andreasen N C., Carpenter Jr W T., Kane J M. et al. Remission in schizophrenia: proposed criteria and rationale for consensus. The American journal of psychiatry 2005 162 (3) 441-449 (Pubitemid 40343909)
25. Lambert M, Karow A, Leucht S et al. Remission in schizophrenia: validity, frequency, predictors, and patients perspective 5 years later. Dialogues in clinical neuroscience 2010 12 (3) 393-407
26. Krack P, Batir A, Van Blercom N et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinsons disease. The New England journal of medicine 2003 349 (20) 1925-1934 (Pubitemid 37409709)
27. Oh M Y., Abosch A, Kim S H. et al. Long-term hardware-related complications of deep brain stimulation. Neurosurgery 2002 50 (6) 1268-1274; discussion 1274 1276
28. Müller S, Christen M. Deep Brain Stimulation in Parkinsonian Patients Ethical Evaluation of Cognitive, Affective, and Behavioral Sequelae. AJOB Neuroscience 2011 2 (1) 3-13
29. McIntyre C C., Savasta M, Kerkerian-Le Goff L et al. Uncovering the mechanism(s) of action of deep brain stimulation: activation, inhibition, or both. Clin Neurophysiol 2004 115 (6) 1239-1248 (Pubitemid 38596707)
30. Dostrovsky J O., Levy R, Wu J P. et al. Microstimulation-induced inhibition of neuronal firing in human globus pallidus. J Neurophysiol 2000 84 (1) 570-574 (Pubitemid 30490074)
31. Beurrier C, Bioulac B, Audin J et al. High-frequency stimulation produces a transient blockade of voltage-gated currents in subthalamic neurons. J Neurophysiol 2001 85 (4) 1351-1356 (Pubitemid 32280576)
32. Leiphart J W., Valone3 rd F H. Stereotactic lesions for the treatment of psychiatric disorders. J Neurosurg 2010 113 (6) 1204-1211
33. Ridding M C., Rothwell J C. Is there a future for therapeutic use of transcranial magnetic stimulation? Nat Rev Neurosci 2007 8 (7) 559-567 (Pubitemid 46985363)
34. Pascual-Leone A, Bartres-Faz D, Keenan J P. Transcranial magnetic stimulation: studying the brain-behaviour relationship by induction of virtual lesions. Philos Trans R Soc Lond B Biol Sci 1999 354 (1387) 1229-1238 (Pubitemid 29400903)
35. Jandl M. The use of repetitive transcranial magnetic stimulation (rTMS) in auditory verbal hallucinations (AVH). Fortschr Neurol Psychiatr 2010 78 (11) 632-643
36. Aleman A, Sommer I E., Kahn R S. Efficacy of slow repetitive transcranial magnetic stimulation in the treatment of resistant auditory hallucinations in schizophrenia: a meta-analysis. The Journal of clinical psychiatry 2007 68 (3) 416-421 (Pubitemid 46506807)
37. Slotema C W., Blom J D., Hoek H W. et al. Should we expand the toolbox of psychiatric treatment methods to include Repetitive Transcranial Magnetic Stimulation (rTMS)? A meta-analysis of the efficacy of rTMS in psychiatric disorders. The Journal of clinical psychiatry 2010 71 (7) 873-884
38. Slotema C W., Blom J D., Weijer A D. et al. Can low-frequency repetitive transcranial magnetic stimulation really relieve medication-resistant auditory verbal hallucinations? Negative results from a large randomized controlled trial. Biological psychiatry 2011 69 (5) 450-456
39. Payne N A., Prudic J de. Electroconvulsive therapy: Part I. A perspective on the evolution and current practice of ECT. Journal of psychiatric practice 2009 15 (5) 346-368
40. Kato N. Neurophysiological mechanisms of electroconvulsive therapy for depression. Neuroscience research 2009 64 (1) 3-11
41. Daniels J. Catatonia: clinical aspects and neurobiological correlates. The Journal of neuropsychiatry and clinical neurosciences 2009 21 (4) 371-380
42. Sanacora G, Mason G F., Rothman D L. et al. Increased cortical GABA concentrations in depressed patients receiving ECT. The American journal of psychiatry 2003 160 (3) 577-579 (Pubitemid 41094271)
43. Northoff G. What catatonia can tell us about top-down modulation: a neuropsychiatric hypothesis. The Behavioral and brain sciences 2002 25 (5) 555-577; discussion 578 604 (Pubitemid 36987059)
44. Mikell C B., McKhann G M., Segal S et al. The hippocampus and nucleus accumbens as potential therapeutic targets for neurosurgical intervention in schizophrenia. Stereotact Funct Neurosurg 2009 87 (4) 256-265
45. Kapur S. Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. Am J Psychiatry 2003 160 (1) 13-23 (Pubitemid 36042420)
46. Kapur S, Mizrahi R, Li M. From dopamine to salience to psychosis linking biology, pharmacology and phenomenology of psychosis. Schizophrenia research 2005 79 (1) 59-68 (Pubitemid 41362593)
47. Goto Y, Otani S, Grace A A. The Yin and Yang of dopamine release: a new perspective. Neuropharmacology 2007 53 (5) 583-587 (Pubitemid 47516678)
48. Kapur S, Mamo D. Half a century of antipsychotics and still a central role for dopamine D 2 receptors. Prog Neuropsychopharmacol Biol Psychiatry 2003 27 (7) 1081-1090 (Pubitemid 37464954)
49. Juckel G, Schlagenhauf F, Koslowski M et al. Dysfunction of ventral striatal reward prediction in schizophrenic patients treated with typical, not atypical, neuroleptics. Psychopharmacology 2006 187 (2) 222-228 (Pubitemid 44015616)
50. Rosenfeld A J., Lieberman J A., Jarskog L F. Oxytocin, Dopamine, and the Amygdala: A Neurofunctional Model of Social Cognitive Deficits in Schizophrenia. Schizophr Bull 2011 37 (5) 1077-1087
51. Harvey P D., Koren D, Reichenberg A et al. Negative symptoms and cognitive deficits: what is the nature of their relationship? Schizophr Bull 2006 32 (2) 250-258
52. Ventura J, Hellemann G S., Thames A D. et al. Symptoms as mediators of the relationship between neurocognition and functional outcome in schizophrenia: a meta-analysis. Schizophr Res 2009 113 (2 3) 189-199
53. Juckel G, Schlagenhauf F, Koslowski M et al. Dysfunction of ventral striatal reward prediction in schizophrenia. Neuroimage 2006 29 (2) 409-416 (Pubitemid 43063297)
54. Niv Y, Daw N D., Joel D et al. Tonic dopamine: opportunity costs and the control of response vigor. Psychopharmacology 2007 191 (3) 507-520 (Pubitemid 46355878)
55. Schlaepfer T E., Cohen M X., Frick C et al. Deep brain stimulation to reward circuitry alleviates anhedonia in refractory major depression. Neuropsychopharmacology 2008 33 (2) 368-377 (Pubitemid 350243349)
56. Hamamura T, Harada T. Unique pharmacological profile of aripiprazole as the phasic component buster. Psychopharmacology 2007 191 (3) 741-743 (Pubitemid 46355901)
57. Mazza M, Squillacioti M R., Pecora R D. et al. Effect of aripiprazole on self-reported anhedonia in bipolar depressed patients. Psychiatry Res 2009 165 (1 2) 193-196
58. Leucht S, Corves C, Arbter D et al. Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. Lancet 2009 373 (9657) 31-41
59. Sandyk R. Pineal and habenula calcification in schizophrenia. Int J Neurosci 1992 67 (1 4) 19-30
60. Corfas G, Roy K, Buxbaum J D. Neuregulin 1-erbB signaling and the molecular/cellular basis of schizophrenia. Nat Neurosci 2004 7 (6) 575-580 (Pubitemid 38691892)
61. Williams N M., Preece A, Spurlock G et al. Support for genetic variation in neuregulin 1 and susceptibility to schizophrenia. Mol Psychiatry 2003 8 (5) 485-487 (Pubitemid 36829690)
62. Yang J Z., Si T M., Ruan Y et al. Association study of neuregulin 1 gene with schizophrenia. Mol Psychiatry 2003 8 (7) 706-9 (Pubitemid 36976302)
63. Steiner H, Blum M, Kitai S T. et al. Differential expression of ErbB3 and ErbB4 neuregulin receptors in dopamine neurons and forebrain areas of the adult rat. Exp Neurol 1999 159 (2) 494-503 (Pubitemid 29485235)
64. Lecourtier L, Kelly P H. Bilateral lesions of the habenula induce attentional disturbances in rats. Neuropsychopharmacology 2005 30 (3) 484-496 (Pubitemid 40271151)
65. Lecourtier L, Neijt H C., Kelly P H. Habenula lesions cause impaired cognitive performance in rats: implications for schizophrenia. Eur J Neurosci 2004 19 (9) 2551-2560 (Pubitemid 38621852)
66. Heldt S A., Ressler K J. Lesions of the habenula produce stress- and dopamine-dependent alterations in prepulse inhibition and locomotion. Brain Res 2006 1073 1074 229-239
67. Shepard P D., Holcomb H H., Gold J M. Schizophrenia in translation: the presence of absence: habenular regulation of dopamine neurons and the encoding of negative outcomes. Schizophr Bull 2006 32 (3) 417-421 (Pubitemid 43992313)
68. Paul G, Reum T, Meissner W et al. High frequency stimulation of the subthalamic nucleus influences striatal dopaminergic metabolism in the naive rat. Neuroreport 2000 11 (3) 441-444 (Pubitemid 30120453)
69. Meissner W, Harnack D, Reese R et al. High-frequency stimulation of the subthalamic nucleus enhances striatal dopamine release and metabolism in rats. J Neurochem 2003 85 (3) 601-609 (Pubitemid 36531923)
70. Meissner W, Harnack D, Paul G et al. Deep brain stimulation of subthalamic neurons increases striatal dopamine metabolism and induces contralateral circling in freely moving 6-hydroxydopamine-lesioned rats. Neurosci Lett 2002 328 (2) 105-108 (Pubitemid 34804722)
71. Meissner W, Reum T, Paul G et al. Striatal dopaminergic metabolism is increased by deep brain stimulation of the subthalamic nucleus in 6-hydroxydopamine lesioned rats. Neurosci Lett 2001 303 (3) 165-168 (Pubitemid 32373281)
72. Winter C, Lemke C, Sohr R et al. High frequency stimulation of the subthalamic nucleus modulates neurotransmission in limbic brain regions of the rat. Exp Brain Res 2008 185 (3) 497-507 (Pubitemid 351239565)
73. Benazzouz A, Piallat B, Pollak P et al. Responses of substantia nigra pars reticulata and globus pallidus complex to high frequency stimulation of the subthalamic nucleus in rats: electrophysiological data. Neurosci Lett 1995 189 (2) 77-80
74. Benazzouz A, Gao D M., Ni Z G. et al. Effect of high-frequency stimulation of the subthalamic nucleus on the neuronal activities of the substantia nigra pars reticulata and ventrolateral nucleus of the thalamus in the rat. Neuroscience 2000 99 (2) 289-295 (Pubitemid 30628416)
75. Benazzouz A, Gao D, Ni Z et al. High frequency stimulation of the STN influences the activity of dopamine neurons in the rat. Neuroreport 2000 11 (7) 1593-1596 (Pubitemid 30365511)
76. Robledo P, Feger J. Excitatory influence of rat subthalamic nucleus to substantia nigra pars reticulata and the pallidal complex: electrophysiological data. Brain Res 1990 518 (1 2) 47-54 (Pubitemid 20197029)
77. Bruet N, Windels F, Carcenac C et al. Neurochemical mechanisms induced by high frequency stimulation of the subthalamic nucleus: increase of extracellular striatal glutamate and GABA in normal and hemiparkinsonian rats. J Neuropathol Exp Neurol 2003 62 (12) 1228-1240 (Pubitemid 37494192)
78. Buzsaki G, Draguhn A. Neuronal oscillations in cortical networks. Science 2004 304 (5679) 1926-1929
79. Uhlhaas P J., Roux F, Singer W et al. The development of neural synchrony reflects late maturation and restructuring of functional networks in humans. Proc Natl Acad Sci U S A 2009 106 (24) 9866-9871
80. Stein A von, Sarnthein J. Different frequencies for different scales of cortical integration: from local gamma to long range alpha/theta synchronization. Int J Psychophysiol 2000 38 (3) 301-313
81. Uhlhaas P J., Singer W. Abnormal neural oscillations and synchrony in schizophrenia. Nat Rev Neurosci 2010 11 (2) 100-113
82. Boutros N. Lack of blinding in gating studies. Schizophr Res 2008 103 (1 3) 336; author reply 337
83. Spencer K M., Nestor P G., Perlmutter R et al. Neural synchrony indexes disordered perception and cognition in schizophrenia. Proc Natl Acad Sci U S A 2004 101 (49) 17 288-17 293
84. Uhlhaas P J., Haenschel C, Nikolic D et al. The role of oscillations and synchrony in cortical networks and their putative relevance for the pathophysiology of schizophrenia. Schizophr Bull 2008 34 (5) 927-943
85. Uhlhaas P J., Linden D E., Singer W et al. Dysfunctional long-range coordination of neural activity during Gestalt perception in schizophrenia. J Neurosci 2006 26 (31) 8168-8175 (Pubitemid 44315141)
86. Haenschel C, Linden D E., Bittner R A. et al. Alpha phase locking predicts residual working memory performance in schizophrenia. Biol Psychiatry 2010 68 (7) 595-598
87. Rolls E T., Loh M, Deco G et al. Computational models of schizophrenia and dopamine modulation in the prefrontal cortex. Nat Rev Neurosci 2008 9 (9) 696-709
88. Teubner M D., Nixon J B., Rasser P E. et al. Source localisation in a real human head. Brain Topogr 2005 17 (4) 197-205 (Pubitemid 40980301)
89. Timmermann L, Gross J, Butz M et al. Pathological oscillatory coupling within the human motor system in different tremor syndromes as revealed by magnetoencephalography. Neurol Clin Neurophysiol 2004 26
90. Timmermann L, Gross J, Dirks M et al. The cerebral oscillatory network of parkinsonian resting tremor. Brain 2003 126 (Pt 1) 199-212 (Pubitemid 36068570)
91. Kuhn A A., Kupsch A, Schneider G H. et al. Reduction in subthalamic 8 35 Hz oscillatory activity correlates with clinical improvement in Parkinsons disease. Eur J Neurosci 2006 23 (7) 1956-1960
92. Kuhn A A., Williams D, Kupsch A et al. Event-related beta desynchronization in human subthalamic nucleus correlates with motor performance. Brain 2004 127 (Pt 4) 735-746 (Pubitemid 38478518)
93. Meissner W, Leblois A, Hansel D et al. Subthalamic high frequency stimulation resets subthalamic firing and reduces abnormal oscillations. Brain 2005 128 (Pt 10) 2372-2382 (Pubitemid 41407976)
94. Gallinat J, Mulert C, Bajbouj M et al. Frontal and temporal dysfunction of auditory stimulus processing in schizophrenia. Neuroimage 2002 17 (1) 110-127
95. Javitt D C. When doors of perception close: bottom-up models of disrupted cognition in schizophrenia. Annu Rev Clin Psychol 2009 5 249-275
96. Adcock R A., Dale C, Fisher M et al. When top-down meets bottom-up: auditory training enhances verbal memory in schizophrenia. Schizophr Bull 2009 35 (6) 1132-1141
97. Arends M, Winterer G. Tiefe Hirnstimulation bei Schizophrenie Ein neues Forschungsprojekt. Nervenarzt 2008 Suppl 4 470
98. Gross A, Joutsiniemi S L., Rimon R et al. Clozapine-induced QEEG changes correlate with clinical response in schizophrenic patients: a prospective, longitudinal study. Pharmacopsychiatry 2004 37 (3) 119-122 (Pubitemid 38680332)
99. Andreasen N C. Scale for the Assessment of Negative Symptoms (SANS). Iowa City University of Iowa Press 1983
100. Gschwandtner U, Zimmermann R, Pflueger M O. et al. Negative symptoms in neuroleptic-naive patients with first-episode psychosis correlate with QEEG parameters. Schizophr Res 2009 115 (2 3) 231-236
101. Singer W. Neuronal synchrony: a versatile code for the definition of relations? Neuron 1999 24 (1) 49-65, 111 125 (Pubitemid 29466147)
102. Mundt A, Klein J, Joel D et al. High-frequency stimulation of the nucleus accumbens core and shell reduces quinpirole-induced compulsive checking in rats. Eur J Neurosci 2009 29 (12) 2401-2412
103. Klavir O, Flash S, Winter C et al. High frequency stimulation and pharmacological inactivation of the subthalamic nucleus reduces compulsive lever-pressing in rats. Exp Neurol 2009 215 (1) 101-109
104. Klavir O, Winter C, Joel D. High but not low frequency stimulation of both the globus pallidus and the entopeduncular nucleus reduces compulsive lever-pressing in rats. Behav Brain Res 2011 216 (1) 84-93
105. Djodari-Irani A, Klein J, Banzhaf J et al. HFS and pharmacological inactivation of the globus pallidus and nucleus entopeduncularis differentially affect quinpirole-induced compulsive checking in rats. European Neuropsychopharmacology 2010 20 S281-S282
106. Winter C, Flash S, Klavir O et al. The role of the subthalamic nucleus in compulsive behavior in rats. Eur J Neurosci 2008 27 (8) 1902-1911 (Pubitemid 351521474)
107. Hamani C, Nobrega J N. Deep brain stimulation in clinical trials and animal models of depression. Eur J Neurosci 2010 32 (7) 1109-1117
108. Hamani C, Diwan M, Macedo C E. et al. Antidepressant-like effects of medial prefrontal cortex deep brain stimulation in rats. Biol Psychiatry 2010 67 (2) 117-124
109. Vassoler F M., Schmidt H D., Gerard M E. et al. Deep brain stimulation of the nucleus accumbens shell attenuates cocaine priming-induced reinstatement of drug seeking in rats. J Neurosci 2008 28 (35) 8735-8739
110. Rouaud T, Lardeux S, Panayotis N et al. Reducing the desire for cocaine with subthalamic nucleus deep brain stimulation. Proc Natl Acad Sci U S A 2010 107 (3) 1196-1200
111. Winter C, Harnack D, Kupsch A. Deep brain stimulation for neurological and psychiatric diseases: animal experiments on effect and mechanisms. Nervenarzt 2010 81 (6) 711-718
112. Feldon J, Weiner I. Editorial: Special issue on modeling schizophrenia. Behav Brain Res 2009 204 (2) 255-257
113. Andreasen N C. The American concept of schizophrenia. Schizophr Bull 1989 15 (4) 519-531 (Pubitemid 20066720)
114. Klosterkotter J. The revised definitions of schizophrenic disorders in ICD-10 and DSM-IV. Fortschr Neurol Psychiatr 1998 66 (3) 133-143 (Pubitemid 28137690)
115. Kirkpatrick B, Fenton W S., Carpenter Jr W T. et al. The NIMH-MATRICS consensus statement on negative symptoms. Schizophr Bull 2006 32 (2) 214-219
116. Carter C S., Barch D M., Buchanan R W. et al. Identifying cognitive mechanisms targeted for treatment development in schizophrenia: an overview of the first meeting of the Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia Initiative. Biol Psychiatry 2008 64 (1) 4-10
117. Nuechterlein K H., Green M F., Kern R S. et al. The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity. Am J Psychiatry 2008 165 (2) 203-213 (Pubitemid 351704520)